What is Regenxbio's EPS (basic)?

Regenxbio (RGNX) reported EPS (basic) of -$1.72 in Q1 2026.

How has Regenxbio's EPS (basic) changed year-over-year?

Regenxbio's EPS (basic) decreased by 1533.3% year-over-year, from $0.12 to -$1.72.

What is the long-term trend for Regenxbio's EPS (basic)?

Over 3 years (2022 to 2025), Regenxbio's EPS (basic) has grown at a -16.7% compound annual growth rate (CAGR), from -$6.51 to -$3.76.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Regenxbio RGNX EPS (Basic)

EPS (Basic) at other companies

Regeneron PharmaceuticalsREGN

$6.99-7.8%

BiogenBIIB

$2.17+31.5%

BioMarin PharmaceuticalsBMRN

$0.55-43.3%

EyePoint, Inc. EYPT

-$0.99-52.3%

Ultragenyx PharmaceuticalRARE

-$1.84-17.2%

4D Molecular TherapeuticsFDMT

-$1.01-17.4%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's EPS (basic)?: Regenxbio (RGNX) reported EPS (basic) of -$1.72 in Q1 2026.
How has Regenxbio's EPS (basic) changed year-over-year?: Regenxbio's EPS (basic) decreased by 1533.3% year-over-year, from $0.12 to -$1.72.
What is the long-term trend for Regenxbio's EPS (basic)?: Over 3 years (2022 to 2025), Regenxbio's EPS (basic) has grown at a -16.7% compound annual growth rate (CAGR), from -$6.51 to -$3.76.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.